Published in Cancer Weekly, October 26th, 2004
"Our patient population differed significantly from those of previous studies as no patients received antimicrobial or CSF prophylaxis before randomization and all were solid tumor patients," scientists writing in the Journal of Chemotherapy report.
"When the diagnosis of FN was established," O. Er and colleagues said, "patients were started on intravenous meropenem 1 g every 8 hours and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.